comparemela.com

Latest Breaking News On - Men enterprises inc - Page 1 : comparemela.com

MedMen Enterprises Inc (OTCMKTS:MMNFF) Short Interest Update

MedMen Enterprises Inc (OTCMKTS:MMNFF) Short Interest Update
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

MedMen Enterprises Inc (OTCMKTS:MMNFF) Short Interest Down 17 0% in January

MedMen Enterprises Inc. (OTCMKTS:MMNFF – Get Free Report) was the recipient of a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 318,800 shares, a drop of 17.0% from the December 31st total of 384,200 shares. Based on an average trading volume of 1,862,300 shares, […]

Scottsdale Dispensary Being Sold to Local Company

Arizona marijuana information and news. Find AZ marijuana dispensaries, doctors, laws, events, news, and more.

2 Hot Marijuana Stocks To Watch This Week

2 Hot Marijuana Stocks To Watch This Week
dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.

The Week In Cannabis: The New Tilray, Jazz-GW Pharma, Earnings, M&A, And More

On Monday, Tilray, Inc. (NASDAQ:TLRY) and Aphria, Inc. (NASDAQ:APHA) closed their merger after months of negotiations, creating a company with a combined market cap of $3.3 billion. Benzinga spoke with Irwin Simon, CEO of the new combined company. Check out the video below: Following the merger, Jefferies upgraded the rating for Tilray from Underperform to Buy, while raising the price target from $4.77 to $23. Jazz Pharmaceuticals (NASDAQ:JAZZ) finalized its acquisition of GW Pharmaceuticals plc. (NASDAQ:GWPH), the producer of the FDA‑approved prescription cannabidiol drug Epidiolex, for $7.2 billion or $6.7 billion net of GW Pharma s cash. Meanwhile, Ascend Wellness Holdings (CSE:AAWH) started trading on the Canadian Securities exchange following a raise of approximately $80 million through an initial public offering of roughly 10 million shares of its Class A common stock at $8 per share.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.